Logo 1 Logo 2

Clinical Trial Details

Trial ID: L5870
Source ID: NCT06125873
Associated Drug: Metformin
Title: Effect of Moringa Leaf Capsules on Glycemic Control of Type 2 Diabetic Patients
Acronym:
Status: ENROLLING_BY_INVITATION
Study Results: NO
Results:
Conditions: Diabetes Mellitus Type 2
Interventions: DRUG: Metformin
Outcome Measures: Primary: Moringa leaf powder decreases blood sugar level in type 2 diabetic patients., Fasting blood glucose tested after 15 days regularly., 3 months|It controls blood Glycated hemoglobin level in type 2 diabetic patients., Glycated Hemoglobin(Hb A1c) tested after 3 months., 3 months | Secondary: Moringa leaf powder effect on Systolic Blood Pressure, Systolic BP will be measured in mm Hg at the start of study and then after every 3 months, 3 months|Moringa leaf powder effect on Diastolic Blood Pressure, Diastolic BP will be measured in mm Hg at the start of study and then after every 3 months, 3 months|Moringa leaf powder effect on body weight of patients, The weight in kg at the start of study and then after every 3 months, 3 months
Sponsor/Collaborators: Sponsor: Islamabad Medical and Dental College
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE2
Enrollment: 50
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: SUPPORTIVE_CARE
Start Date: 2023-03-15
Completion Date: 2024-08-01
Results First Posted:
Last Update Posted: 2023-11-09
Locations: Islamabad Medical and Dental College, Islamabad, Federal, 44000, Pakistan
URL: https://clinicaltrials.gov/show/NCT06125873